Discussion on Investigation of new Sars-Cov-2 variant in India called B.1.617 in laboratory

There are no comments for this item yet.

Multiple end products, free or commercial, up to 500,000 total copies (unlimited for web). No merchandise use. The total price includes the item price and a buyer fee.

License details | Why buy with Envato

Multiple end products, plus unlimited copies and merchandise use. The total price includes the item price and a buyer fee.

License details | Why buy with Envato

Price is in US dollars and excludes tax and handling fees

felipecaparros

View Portfolio

Last Update	6 May 2021
Tags	antibiotics, antibodies, antibody testing, B.1.617, concept, contagious, coronavirus, covid-19, dangerous, dead, death, diagnosis, die, epidemic, experimental, human, illness, infect, infection, infectious, influenza, inject, kerala, laboratory, Lethal, maharastra, medical, medication, medicine, new strain indian, new variant Indian, pandemic, patient, pharmaceutical, pneumonia, respiratory, sars-cov-2, science, sickness, symptoms, syndrome, toxic, treatment, vaccine, viral, virology, virus
Created	5 years ago

More Attributes Fewer Attributes